| |
| |
|
| Insider
Information: |
Bozigian Haig P. |
| Relationship: |
Chief Development Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
157,651 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$22,146,812 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,651 |
|
|
| Total
Value |
$22,146,812 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-13 |
4 |
OE |
$8.66 |
$299,177 |
D/D |
34,547 |
176,523 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-16 |
4 |
AS |
$80.13 |
$5,341,893 |
D/D |
(66,667) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-16 |
4 |
OE |
$5.76 |
$1,171,789 |
D/D |
66,667 |
142,707 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-22 |
4 |
OE |
$19.59 |
$25,467 |
D/D |
1,300 |
143,276 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-22 |
4 |
AS |
$80.03 |
$104,037 |
D/D |
(1,300) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-24 |
4 |
OE |
$19.59 |
$342,551 |
D/D |
17,486 |
159,462 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-24 |
4 |
AS |
$80.03 |
$1,399,434 |
D/D |
(17,486) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-31 |
4 |
AS |
$85.02 |
$1,640,581 |
D/D |
(19,297) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-31 |
4 |
OE |
$19.59 |
$378,028 |
D/D |
19,297 |
161,273 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-03 |
4 |
AS |
$85.51 |
$293,719 |
D/D |
(3,435) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-03 |
4 |
OE |
$19.59 |
$67,292 |
D/D |
3,435 |
145,411 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-13 |
4 |
OE |
$19.59 |
$357,469 |
D/D |
17,268 |
143,408 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-13 |
4 |
AS |
$82.56 |
$1,426,628 |
D/D |
(17,268) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-18 |
4 |
OE |
$32.99 |
$69,279 |
D/D |
2,100 |
144,076 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-18 |
4 |
AS |
$87.82 |
$184,417 |
D/D |
(2,100) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-10 |
4 |
OE |
$32.99 |
$234,889 |
D/D |
7,120 |
149,096 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-10 |
4 |
AS |
$87.63 |
$623,958 |
D/D |
(7,120) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-11 |
4 |
OE |
$32.99 |
$3,299 |
D/D |
100 |
142,076 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-11 |
4 |
AS |
$87.59 |
$8,759 |
D/D |
(100) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-15 |
4 |
AS |
$87.50 |
$2,684,506 |
D/D |
(30,680) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-15 |
4 |
OE |
$32.99 |
$1,012,133 |
D/D |
30,680 |
172,656 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-30 |
4 |
OE |
$32.99 |
$1,725,704 |
D/D |
44,356 |
167,576 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-30 |
4 |
AS |
$91.74 |
$4,114,858 |
D/D |
(44,356) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-02-05 |
4 |
AS |
$103.00 |
$210,779 |
D/D |
(2,046) |
143,925 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-02-06 |
4 |
AS |
$101.56 |
$141,670 |
D/D |
(1,395) |
145,180 |
0 |
% |
|
92 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
